scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1014853315 |
P356 | DOI | 10.1007/S00198-007-0386-0 |
P698 | PubMed publication ID | 17492247 |
P5875 | ResearchGate publication ID | 6340181 |
P50 | author | Karl Michaëlsson | Q44118143 |
Anders Ahlbom | Q62592795 | ||
P2093 | author name string | Ljunghall S | |
Farahmand B | |||
Sennerby U | |||
P2860 | cites work | RANK-L and RANK: T cells, bone loss, and mammalian evolution | Q28203468 |
Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial | Q28237610 | ||
Homocysteine levels and the risk of osteoporotic fracture | Q28261532 | ||
Homocysteine as a predictive factor for hip fracture in older persons | Q28261544 | ||
Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin | Q28295204 | ||
Adipose tissue as an endocrine organ | Q29620407 | ||
Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. | Q33199008 | ||
The role of calcium in health and disease | Q33796941 | ||
Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group | Q33805259 | ||
Long-Term fracture risk following ischemic stroke: a population-based study | Q34502363 | ||
Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis | Q35204725 | ||
Homocysteine and Essential Hypertension | Q35582716 | ||
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology | Q35640443 | ||
Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? | Q35700564 | ||
Modulation of osteoclast differentiation | Q35957509 | ||
The validity of a diagnosis of heart failure in a hospital discharge register | Q36139616 | ||
Putting cardiovascular disease and vitamin D insufficiency into perspective | Q36273545 | ||
Bisphosphonates and atherosclerosis: why? | Q36283520 | ||
Cardiovascular disease and osteoporosis. | Q36427035 | ||
Validity of register data on acute myocardial infarction and acute stroke: the Skaraborg Hypertension Project | Q36780112 | ||
Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation | Q37286240 | ||
Mortality after all major types of osteoporotic fracture in men and women: an observational study. | Q39490012 | ||
Radiographic measure of aorta calcification is a site-specific predictor of bone loss and fracture risk at the hip. | Q40324778 | ||
Relationship between osteoporosis and cardiovascular disease in postmenopausal women | Q40380006 | ||
Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure | Q43919813 | ||
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study | Q44433022 | ||
Bone mineral density and mortality in women and men: the NHANES I epidemiologic follow-up study | Q44643697 | ||
Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. | Q44683819 | ||
Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women | Q46130374 | ||
Aortic calcification and the risk of osteoporosis and fractures | Q46548686 | ||
Usefulness of bone mineral density to predict significant coronary artery disease | Q46743721 | ||
Adiponectin as a novel determinant of bone mineral density and visceral fat. | Q47447230 | ||
Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. | Q53594009 | ||
High blood pressure and bone-mineral loss in elderly white women: a prospective study | Q58217372 | ||
Predictive Value of BMD for Hip and Other Fractures | Q59755508 | ||
Survival after hip fracture | Q59806044 | ||
Oral-contraceptive use and risk of hip fracture: a case-control study | Q59806704 | ||
Aging and calcium as an environmental factor | Q70010543 | ||
Difference in the effect of adiposity on bone density between pre- and postmenopausal women | Q73549356 | ||
Circulating oxidized low-density lipoprotein is increased in hypertension | Q73598452 | ||
Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study | Q77084584 | ||
The association between low bone mass at the menopause and cardiovascular mortality | Q77220380 | ||
Mortality after osteoporotic fractures | Q79238409 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cardiovascular disease | Q389735 |
cardiovascular disease in women | Q105047283 | ||
P304 | page(s) | 1355-1362 | |
P577 | publication date | 2007-05-10 | |
P1433 | published in | Osteoporosis International | Q7107640 |
P1476 | title | Cardiovascular diseases and future risk of hip fracture in women | |
P478 | volume | 18 |
Q35620276 | (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis. |
Q36269177 | Abdominal aortic calcification and risk of fracture among older women - The SOF study. |
Q54656348 | Abdominal aortic calcification and the risk of bone fractures: a meta-analysis of prospective cohort studies. |
Q37056404 | Association between cardiovascular diseases and osteoporosis-reappraisal |
Q55279441 | Association between preoperative high sensitive troponin I levels and cardiovascular events after hip fracture surgery in the elderly. |
Q34616983 | Association of Paraoxonase 1 (PON1) polymorphisms with osteoporotic fracture risk in postmenopausal Korean women. |
Q99588192 | Association of bone mineral density and trabecular bone score with cardiovascular disease |
Q35540955 | Association of history of fracture with prehypertension and hypertension: a retrospective case-control study |
Q37176133 | Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities? |
Q38972521 | Bone Microarchitecture in Type 1 Diabetes: It Is Complicated |
Q38902954 | Can osteoporosis increase the incidence of heart failure in adults? |
Q36554581 | Cardiovascular and noncardiovascular disease associations with hip fractures |
Q37018972 | Cardiovascular disease and hip fracture among older inpatients in Beijing, China |
Q34177411 | Cardiovascular risk factor analysis in patients with a recent clinical fracture at the fracture liaison service. |
Q44584358 | Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008. |
Q36070138 | Comparison of calibrated and uncalibrated bone mineral density by CT to DEXA in menopausal women |
Q46184082 | Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study |
Q35156275 | Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: the health, aging, and body composition study |
Q36381796 | Do concomitant fractures with hip fractures influence complication rate and functional outcome? |
Q49164967 | FRAX® Fracture Risks Are Associated with Coronary Artery Calcification Score |
Q90288564 | Factors and Outcome of Renal Osteodystrophy-Associated Initial Fragility Fracture in End-Stage Renal Disease Patients |
Q35608491 | HDL cholesterol and bone mineral density: is there a genetic link? |
Q37605328 | High hip fracture risk in men with severe aortic calcification: MrOS study. |
Q35989863 | Hip Fracture in People with Erectile Dysfunction: A Nationwide Population-Based Cohort Study |
Q44261942 | Hip fracture and risk of acute myocardial infarction: a nationwide study |
Q33568103 | Hip fractures and heart failure: findings from the Cardiovascular Health Study. |
Q36792733 | Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women |
Q80738555 | Increased augmentation index and central aortic blood pressure in osteoporotic postmenopausal women |
Q37115439 | Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties. |
Q57168590 | Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis |
Q39976301 | Male risk factors for hip fracture-a 30-year follow-up study in 7,495 men. |
Q46438287 | Mapping the prescriptiome to fractures in men--a national analysis of prescription history and fracture risk |
Q39265913 | Meta-analysis of hypertension and osteoporotic fracture risk in women and men. |
Q92989218 | Modulation of Bone and Marrow Niche by Cholesterol |
Q90385671 | Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication |
Q90264175 | Nonlinear association between bone mineral density and all-cause mortality: the Dong-gu study |
Q37155892 | Osteoporosis epidemiology update |
Q36282512 | Osteoporosis in adult patients with atopic dermatitis: A nationwide population-based study |
Q34914272 | Osteoporotic fractures and heart failure in the community |
Q57068590 | Peripheral artery disease and osteoporosis: Not only age‑related (Review) |
Q36883821 | Physical Functioning Among Women Aged 80 Years and Older With Previous Fracture |
Q34469229 | Polymorphisms in the inflammatory genes CIITA, CLEC16A and IFNG influence BMD, bone loss and fracture in elderly women |
Q37300282 | Predictors of early mortality after hip fracture surgery. |
Q40534297 | Risk Factors for Hip Fracture in Older Men: The Osteoporotic Fractures in Men Study (MrOS). |
Q36978768 | Risk of major osteoporotic fracture after cardiovascular disease: a population-based cohort study in Taiwan |
Q37328920 | Risks of all-cause and site-specific fractures among hospitalized patients with COPD. |
Q36850919 | Severity of aortic calcification is positively associated with vertebral fracture in older men--a densitometry study in the STRAMBO cohort |
Q48061664 | Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice. |
Q38835862 | Stroke increases the risk of hip fracture: a systematic review and meta-analysis |
Q38656103 | The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk. |
Q33589913 | The association between aortic calcification and fracture risk in postmenopausal women in China: the prospective Chongqing osteoporosis study |
Search more.